ECHOIQ LIMITED — Investor Relations & Filings

EchoIQ Limited is a medical technology company specializing in the development of artificial intelligence and machine learning solutions for the healthcare sector. The company focuses on enhancing the diagnosis and risk assessment of structural heart disease through its flagship platform, EchoSolv. This cloud-based clinical decision support tool utilizes proprietary algorithms to analyze echocardiographic measurement data, identifying patients at risk of conditions such as aortic stenosis and heart failure. By comparing individual patient data against established clinical guidelines and extensive cardiovascular datasets, the technology assists clinicians in detecting under-diagnosed or misdiagnosed cardiac conditions. The platform is designed to integrate into existing clinical workflows, aiming to improve diagnostic accuracy, optimize patient management, and support timely intervention in cardiovascular care.